Lisdexamfetamine Dimesylate for the Treatment of Attention Deficit Hyperactivity Disorder in Adults With a History of Depression or History of Substance Use Disorder

| February 28, 2011 | 0 Comments


by Scott H. Kollins, PhD; Sharon Youcha, MD; Robert Lasser, MD, MBA; and Michael E. Thase, MD
Dr. Kollins is from Duke ADHD Program, Duke University Medical Center, Durham, North Carolina; Drs. Youcha and Lasser are from Shire Development Inc., Wayne, Pennsylvania; and Dr. Thase is from the Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.

Innov Clin Neurosci. 2011;8(2):28–32

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , ,

Category: Attention Deficit Hyperactivity Disorder, Brief Report, Child Adol Mental Disorders, Psychiatry, Report

Leave a Reply